*1 indicates case definition and diagnostic appropriate; 2, consecutive patients or case having a good representation; 3, community controls; 4, control with no the history of study disease; 5A, accor
(1) End points: A, Endpoints appropriate to the aim of the study; B, no description about endpoints; C, endpoints inappropriate to the aim of the study. (2) Follow-up period: A, follow-up appropriate
